1. Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing, standards, 3D bioprinting, artificial intelligence‐enabled automation, education, and training. (28th March 2020) Authors: Hunsberger, Joshua; Simon, Carl; Zylberberg, Claudia; Ramamoorthy, Preveen; Tubon, Thomas; Bedi, Ram; Gielen, Kurt; Hansen, Caitlin; Fischer, Lynn; Johnson, Jed; Baraniak, Priya; Mahdavi, Behzad; Pereira, Taciana; Hadjisavas, Michael; Eaker, Shannon; Miller, Cameron Journal: Stem cells translational medicine Issue: Volume 9:Number 7(2020) Page Start: 728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing, standards, 3D bioprinting, artificial intelligence-enabled automation, education, and training. (28th March 2020) Authors: Hunsberger, Joshua; Simon, Carl; Zylberberg, Claudia; Ramamoorthy, Preveen; Tubon, Thomas; Bedi, Ram; Gielen, Kurt; Hansen, Caitlin; Fischer, Lynn; Johnson, Jed; Baraniak, Priya; Mahdavi, Behzad; Pereira, Taciana; Hadjisavas, Michael; Eaker, Shannon; Miller, Cameron Journal: Stem cells translational medicine Issue: Volume 9:Number 7(2020) Page Start: 728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Process change evaluation framework for allogeneic cell therapies: impact on drug development and commercialization. (April 2016) Authors: Hassan, Sally; Huang, Hsini; Warren, Kim; Mahdavi, Behzad; Smith, David; Jong, Simcha; Farid, Suzanne S Journal: Regenerative medicine Issue: Volume 11:Number 3(2016) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗